AI assistant
CVS HEALTH Corp — Director's Dealing 2021
Mar 23, 2021
29875_dirs_2021-03-23_391dcb22-76e9-4338-923c-a1a2e729a5d6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2021-03-19
Reporting Person: Moriarty Thomas M (EVP & General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-19 | Common Stock | S | 49211 | $74.15 | Disposed | 18226.0221 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock (restricted) | 12778 | Direct |
| Stock Unit | 45455.2448 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $74.29 | 2021-04-01 | Common Stock (62943) | 62943 | Direct |
| Stock Option | $102.26 | 2022-04-01 | Common Stock (51361) | 51361 | Direct |
| Stock Option | $104.82 | 2023-04-01 | Common Stock (71696) | 71696 | Direct |
| Stock Option | $78.05 | 2024-04-03 | Common Stock (125224) | 125224 | Direct |
| Stock Option | $62.21 | 2025-04-01 | Common Stock (145959) | 145959 | Direct |
| Stock Option | $54.19 | 2029-04-01 | Common Stock (202007) | 202007 | Direct |
| Stock Option | $58.34 | 2030-04-01 | Common Stock (197116) | 197116 | Direct |
Footnotes
F1: All sales were effected pursuant to a Rule 10b5-1 plan.
F2: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $74.00 and $74.58 per share.
F3: Option became exercisable in four equal annual installments, commencing 4/1/2015.
F4: Option became exercisable in four equal annual installments, commencing 4/1/2016.
F5: Option became exercisable in four equal annual installments, commencing 4/1/2017.
F6: Option became exercisable in four equal annual installments, commencing 4/3/2018.
F7: Option became exercisable in four equal annual installments, commencing 4/1/2019.
F8: Option became exercisable in four equal annual installments, commencing 4/1/2020.
F9: The number of shares subject to the option were calculated using a 30-day average price.
F10: Option becomes exercisable in four equal annual installments, commencing 4/1/2021.